MPLT MapLight Therapeutics, Inc.
$13.00▼ -5.69%
Healthcare
Other
After hours
$13.00▲ +0.00%
Sep 11, 7:30 PM ET
Volume 340.2K
Avg Volume (10D) 560.1K
Key Metrics & Fundamentals
Market Cap
$602.91M
P/E Ratio
–
Div Yield
–%
52W Range
9.10 - 40.43
% vs 50 MA
-36.37%
% vs 200 MA
-40.79%
RSI-14
40.2
MACD Histogram
+0.6900
Beta (1Y vs SPY)
0.86
Free Cash Flow
-$44.89M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$63.40M
COGS
–
Operating Exp
$63.55M
Operating Income
-$63.55M
EBIT
-$63.55M
Pretax Income
-$60.19M
Net Income
-$60.19M
EPS (Diluted)
-1.32
Price & Volume History
Loading chart…
Recent News
IPO Stock LB Pharma Has Tripled In Under A Year. Is It A Takeover Target?
Investor's Business Daily · Sep 9, 2026 12:00 PM
MapLight Therapeutics to Participate in Upcoming Investor Conference
GlobeNewswire · Sep 9, 2026 11:00 AM
AstraZeneca scores in lung cancer; Sandoz inks a China deal
BioPharma Dive · Aug 18, 2026 11:13 AM
MapLight Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 13, 2026 8:05 PM
Sector Update: Healthcare Stocks Softer Late Afternoon
MT Newswires · Aug 13, 2026 7:36 PM
Sector Update: Healthcare Stocks Softer in Afternoon Trading
MT Newswires · Aug 13, 2026 5:50 PM
MapLight Therapeutics Launching $150 Million Private Placement Financing
MT Newswires · Aug 13, 2026 1:47 PM
MapLight Therapeutics Announces $150 Million Private Placement Financing
GlobeNewswire · Aug 13, 2026 1:10 PM
UBS Downgrades MapLight Therapeutics to Neutral From Buy, Adjusts PT to $13 From $52
MT Newswires · Aug 10, 2026 11:43 AM
MapLight CEO on what investors missed in the biotech’s schizophrenia data
BioPharma Dive · Jul 29, 2026 5:22 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MPLT's money flow as a full page
Social Sentiment
No Reddit posts found for MPLT.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.